Thinking up tomorrow's medicine
After running more than 300 early trials and treating 1 200 patients and since obtaining CLIP2 certification, the dynamism of Clinical Research of Nantes University Hospital and the ICO (West Cancer Institute) has been recognized by the National Cancer Institute (INCa). This certification which is given to the best French centers who have the capacity to conduct early stage clinical trials in cancer, will help to facilitate the access of French patients to innovative molecules and showcase French research with the aim of making it more attractive and of facilitating exchanges with international laboratories.
The DiViNe initiative, a joint European collaboration of renowned experts, convinced the European Commission. Its main concept is “positive“ vaccines purification by affinity chromatography based on 2 innovative nanotechnologies for higher yield and lower footprint. The six participating partners, among which Affilogic, member of Atlanpole Biotherapies, will receive more than €5.8 million in financial support from the new EU’s Horizon 2020 Framework Program.
TRONICO is certified ISO 13485 for the scope "industrialisation, circuit board manufacturing, mechanical and eletronic integration and repair of electronic subassemblies for medical devices", since 27th July 2015. The audit was carried out by Bureau Veritas in June, in the facilities of St Philbert de Bouaine (85), and did not show any noncompliance. This certification guarantees an optimum quality level for the manufacture of electronic systems dedicated to medical sector. Tronico is an administrator member of Atlanpole Biotherapies, vice-President for "innovative technologies for biotherapies".
Meet on the Isotop4Life's booth the actors of the Western France radiopharmaceutical sector : Lemer Pax, Keosys, Triskem, Ai4R, Chelatec, Medisystem, Arronax, Academic Corner.
Next Edition of NanoFar's Autumn School will take place from Monday 26th to Friday 30th of October 2015 in Nantes, France. Sessions will be held at the Institut de Recherche en Santé (Institute of Health Research), a major player in the development of research in biology or cognitive therapy.
The Atlanpole Biotherapies competitive cluster combines the expertise of laboratories, companies and technical departments for a public-private offer of services, comprehensive, relevant and competitive, in the value chain of bio-medicine from target discovery to clinical evaluation.
Our ambition is to become a reference center on an international scale for the development of diagnostic and therapeutic solutions in the field of biotherapies.
Atlanpole Biotherapies is a competitive cluster certified by the Ministry of Industry (July 2005).